Joseph H. Crabb Ph.D.
Net Worth

Last updated:

What is Joseph H. Crabb Ph.D. net worth?

The estimated net worth of Dr. Joseph H. Crabb Ph.D. is at least $1,890,122 as of 26 Nov 2018. He owns shares worth $620,155 as insider, has earned $115,387 from insider trading and has received compensation worth at least $1,154,580 in ImmuCell Corporation.

What is the salary of Joseph H. Crabb Ph.D.?

Dr. Joseph H. Crabb Ph.D. salary is $54,980 per year as Vice President & Chief Scientific Officer in ImmuCell Corporation.

How old is Joseph H. Crabb Ph.D.?

Dr. Joseph H. Crabb Ph.D. is 70 years old, born in 1955.

What stocks does Joseph H. Crabb Ph.D. currently own?

As insider, Dr. Joseph H. Crabb Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
ImmuCell Corporation (ICCC) Vice President & Chief Scientific Officer 105,111 $5.9 $620,155

What does ImmuCell Corporation do?

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

ICCC logo
ICCC
ImmuCell Corporation
$5.9

Joseph H. Crabb Ph.D. insider trading

ImmuCell Corporation

Dr. Joseph H. Crabb Ph.D. has made 11 insider trades between 2004-2018, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 47,500 units of ICCC stock on 26 Nov 2018. As of 26 Nov 2018 he still owns at least 105,111 units of ICCC stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock, par value $0.10 per share 47,500 $1.7 $80,750
Sale
Common Stock, par value $0.10 per share 1,935 $6.55 $12,668
Sale
Common Stock, par value $0.10 per share 1,935 $6.55 $12,668
Sale
Common Stock, par value $0.10 per share 265 $6.56 $1,738
Sale
Common Stock, par value $0.10 per share 265 $6.56 $1,738
Sale
Common Stock, par value $0.10 per share 2,426 $6.59 $15,982
Sale
Common Stock, par value $0.10 per share 2,426 N/A N/A
Sale
Common Stock, par value $0.10 per share 2,600 $6.6 $17,160
Sale
Common Stock, par value $0.10 per share 2,574 $6.75 $17,364
Sale
Common Stock, par value $0.10 per share 2,574 $6.75 $17,364
Sale
Common Stock, par value $0.10 per share 2,574 $6.75 $17,364
Sale
Common Stock, par value $.10 per share 200 $6.7 $1,340
Option
Incentive Stock Options 1,000 $3.1 $3,100
Option
Common Stock 1,000 $3.1 $3,100
Purchase
Common Stock 1,000 $3.2 $3,200
Purchase
Common Stock, par value $0.10 per share 1,000 $2 $2,000
Purchase
Common Stock, par value $0.10 per share 23,000 $1.31 $30,199
Purchase
Common stock, par value $0.10 per share 1,000 $3.5 $3,500
Purchase
Common stock, par value $0.10 per share 500 $3.74 $1,870
Option
Common Stock, par value $0.10 per share 12,000 $4 $48,000
Option
Incentive stock options (right to buy) 12,000 $4 $48,000
Option
Common Stock, par value $0.10 per share 500 $1.69 $844
Option
Incentive stock options (right to buy) 500 $1.69 $844
Option
Common Stock, par value $0.10 per share 30,500 $1.94 $59,109
Option
Incentive stock options (right to buy) 30,500 $1.94 $59,109
Option
Incentive stock options (right to buy) 10,000 $2.06 $20,630
Option
Common Stock, par value $0.10 per share 10,000 $2.06 $20,630

ImmuCell key executives

ImmuCell Corporation executives and other stock owners filed with the SEC: